Oral administration of oligo fucoidan improves the survival rate, quality of life, and immunity in patients with lung cancer.

Food Nutr Res · 2024 · PMC11227263 · PMID 38974912

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, it’s worth noting that this difference did not reach statistical significance.

also in 111,027 other papers

a decreasing trendno p-value reported

an increasing trendno p-value reported

Pain, dyspnoea, and insomnia showed a decreasing trend in the fucoidan group and an increasing trend in the control group during the study period.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.